Live from the NIH registry
Studies recruiting near Milwaukee right now
Top 25 of 698 recruiting studies, sorted by proximity — each links to its official registry page
CIBMTR Research Database
Autologous Stem Cell Transplantation, Allogeneic Stem Cell Transplantation
N/A
Observational 99,999,999 participants sought
Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Center for International Blood and Marrow Transplant Research
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
Froedtert and Medical College of Wisconsin - Clinical Cancer Center (Adults only) — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Pierre Fabre Medicament
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Generalized Myasthenia Gravis
N/A
Observational 500 participants sought
Clinical Trial Site — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
External Pharyngeal Exerciser and Dysphagia
Dysphagia
N/A
Interventional 160 participants sought
Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Medical College of Wisconsin
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary
Phase 1, Phase 2
Interventional 200 participants sought
Froedtert & the Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Volastra Therapeutics, Inc.
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma
Phase 1
Interventional 12 participants sought
Froedtert & the Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Medical College of Wisconsin
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Medical College of Wisconsin ( Site 0103) — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Phase 2
Interventional 100 participants sought
MCW-Clinical Cancer Center at Froedtert Hospital Campus — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: C4 Therapeutics, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Ascension Medical Group Southeast Wisconsin - Mayfair Road — Wauwatosa, Wisconsin (2.3 mi)
· Sponsor: SWOG Cancer Research Network
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma
Phase 4
Interventional 787 participants sought
Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Eli Lilly and Company
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Sameek Roychowdhury
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer Site in Wilwaukee, WI — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Mediar Therapeutics
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Acute Myeloid Leukemia (AML)
Phase 3
Interventional 1,300 participants sought
Froedtert & Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Kura Oncology, Inc.
A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors
Advanced Solid Tumor
Phase 1
Interventional 105 participants sought
Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: BeOne Medicines
A Study of Buntanetap in Participants With PD
Parkinson's Disease (PD), Deep Brain Stimulation
Phase 2, Phase 3
Interventional 500 participants sought
Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Annovis Bio Inc.
Study to Enable New Diagnostics for Pulmonary Microbes in People With CF
Cystic Fibrosis (CF), New Diagnostics
N/A
Observational 300 participants sought
Froedtert & Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Chris Goss
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)
Phase 2
Interventional 113 participants sought
Froedtert & Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Anagram Therapeutics, Inc.
A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury
Traumatic Brain Injury
N/A
Observational 2,000 participants sought
Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Hoffmann-La Roche
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Pulmonary Invasive Fungal Infections, Pulmonary Invasive Aspergillosis
N/A
Observational 400 participants sought
Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Arkansas Children's Hospital Research Institute
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Aurora Cancer Care-Milwaukee West — Wauwatosa, Wisconsin (2.3 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)
Viral Infection, Primary Immune Deficiency Disorder
Phase 1, Phase 2
Interventional 40 participants sought
Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: New York Medical College
Striated Esophageal Motor Function Modulation in Health and Disease
Dysphagia, Esophageal
N/A
Interventional 557 participants sought
Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Medical College of Wisconsin
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma
Phase 1
Interventional 65 participants sought
Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: National Cancer Institute (NCI)
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
UW Cancer Center at ProHealth Care — Waukesha, Wisconsin (13.8 mi)
· Sponsor: NRG Oncology
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis
Phase 1
Interventional 20 participants sought
Up0122 101 — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: UCB Biopharma SRL